Latest News Videos

BrainsWay’s strong financial performance pushed its stock to a new high, while Maze continues to gain momentum ahead of an important clinical trial readout. Meanwhile, GSK secured the FDA reapproval of one of its drugs and expanded the label of its RSV vaccine to reach more at-risk adults. These are some of the key stories we are covering in this video.

The week saw no cooling of the tensions in the Middle East that kept pushing the crude oil and gold prices higher, worsening concerns over the overall impact on the global economy. On the data front, latest inflation and foreign trade data were the highlights in the U.S. Trade was also in focus in Europe as Germany released its figures for January. In Asia, Japan revised its growth figure for the fourth quarter and China published external trade data for the first two months of the year.

The week saw a drastic escalation of the war in the Middle East that raised concerns over the effect on crude oil prices and global trade. In economic news, survey data threw light on the trends in the U.S. private sector and labor market. Euro area inflation data and house price survey results in the U.K. were the highlights in Europe. In Asia, China setting its growth target for the year attracted attention.

The week saw central bank action from major economies as policymakers decided on interest rate settings. Private sector survey data for the manufacturing and services sectors were in focus in the U.S. along with some data on the labor market. In Europe, central bank decisions from the euro area and the U.K. gained attention. In the Asia-Pacific, the main news came from the Reserve Bank of Australia that announced its latest interest rate decision.